Socio Today
The prevalence of Congenital Heart Disease (CHD) in Indonesia remains a significant public health challenge, standing as the second leading cause of neonatal mortality in the country. While the exact etiology of CHD often remains elusive to medical science, healthcare experts are increasingly focusing on identifiable and preventable risk factors during pregnancy to mitigate the incidence of infants born with cardiac structural abnormalities. Dr. Rizky Adriansyah, MKed, a pediatric specialist and the Chairman of the Cardiology Coordination Unit of the Indonesian Pediatric Society (IDAI), recently emphasized that while a direct cause-and-effect relationship is difficult to pinpoint in every case, there are several critical factors during gestation that significantly elevate the risk of a child developing heart complications.
According to data presented during a health webinar in early 2023, the Indonesian medical community is prioritizing three specific risk factors that have gained prominence in recent clinical literature: maternal infections—specifically rubella—folic acid deficiency, and the consumption of certain medications, such as anti-seizure drugs, during pregnancy. These factors are known to interfere with the delicate process of fetal organogenesis, particularly during the first trimester when the heart undergoes its primary formation. Dr. Rizky noted that while lifestyle choices such as smoking and alcohol consumption have long been associated with CHD, the medical community frequently encounters cases where infants are born with heart defects despite the mother having no history of tobacco or alcohol use, suggesting that environmental and nutritional factors play a much larger role than previously understood.
The Statistical Burden of Congenital Heart Disease in Indonesia
To understand the scale of the issue, one must look at the data provided by the World Health Organization (WHO) and Indonesian health authorities. Globally, approximately one in every 100 newborns is diagnosed with Congenital Heart Disease. Within that group, an estimated 25 percent suffer from "critical" CHD, a condition that typically requires surgical intervention or specialized medical management within the first year of life—often within the first few days or weeks—to ensure survival.
In the Indonesian context, the 2017 national health data paints a sobering picture. CHD accounts for 17 percent of all neonatal deaths, surpassed only by complications arising from prematurity. This makes it a primary target for the Ministry of Health’s initiatives to reduce infant mortality rates. However, a significant gap remains between the number of cases born and the number of cases treated. Dr. Rizky revealed that currently, less than 50 percent of CHD cases in Indonesia receive the necessary medical or surgical intervention. This discrepancy is attributed to a complex web of challenges, including limited access to specialized cardiac centers, a shortage of pediatric cardiologists and cardiovascular surgeons, inadequate diagnostic equipment in rural areas, and a general lack of public awareness regarding the early signs of heart distress in infants.
Identifying Preventable Risk Factors During Pregnancy
The prevention of CHD must begin well before a child is born. Because the heart is one of the first organs to develop in an embryo, the maternal environment during the first eight weeks of pregnancy is paramount.
-
Rubella Infection and Vaccination: One of the most preventable causes of CHD is Congenital Rubella Syndrome (CRS). When a pregnant woman contracts the rubella virus, it can cause severe birth defects, including deafness, cataracts, and complex heart malformations. Dr. Rizky stressed that the most effective way to prevent this is through the rubella vaccine. Ensuring that women of childbearing age are immunized before they become pregnant creates a "shield" that protects the fetus from viral interference during cardiac development.
-
Folic Acid Supplementation: Folic acid, or Vitamin B9, is essential for DNA synthesis and repair. While its role in preventing neural tube defects like spina bifida is well-documented, emerging research and clinical consensus highlight its necessity in preventing cardiac defects. Many pregnancies in Indonesia are unplanned, meaning mothers may not begin taking supplements until they are several weeks pregnant—potentially after the window of heart development has closed. Experts advocate for fortifying diets with folate-rich foods and ensuring that women planning a pregnancy begin supplementation early.
-
Medication Management: The use of certain pharmaceuticals during pregnancy can be teratogenic (causing developmental malformations). Anti-epileptic drugs, certain acne medications (like isotretinoin), and some blood pressure medications are known to increase the risk of CHD. Dr. Rizky advises that women with chronic conditions must consult their physicians to adjust their prescriptions to pregnancy-safe alternatives before conceiving.
The Challenge of Early Detection and Diagnosis
In Indonesia, many children with CHD are not diagnosed until their condition becomes critical or irreversible. The delay in diagnosis is often the result of the subtle nature of the symptoms. Common clinical signs include slow weight gain (failure to thrive), difficulty breathing while feeding, and a bluish tint to the skin (cyanosis). In cases of critical CHD, symptoms may appear within the first 24 to 48 hours of life, but if a baby is born at home or in a facility without specialized screening, these signs can be easily missed.
To combat this, the IDAI is promoting the use of pulse oximetry as a standard screening tool for all newborns. Pulse oximetry is a non-invasive, fast, and cost-effective method to measure oxygen saturation in the blood. By placing sensors on the baby’s right hand and either foot, healthcare providers can detect differences in oxygen levels that might indicate a heart defect. If the screening shows abnormal results, the infant can be referred for an echocardiography—an ultrasound of the heart—which provides a definitive diagnosis.
"Currently, oximetry is a highly sensitive and affordable tool," Dr. Rizky explained. He noted that the procedure takes less than five minutes and can be performed by midwives or general practitioners in community health centers (Puskesmas). This decentralization of screening is vital for a country as geographically diverse as Indonesia, where many families live far from major urban hospitals.
Addressing the Human Resource and Infrastructure Gap
The fact that less than half of CHD cases are handled in Indonesia highlights a systemic issue in the healthcare hierarchy. Most pediatric cardiac surgeries are concentrated in a few top-tier hospitals, primarily in Jakarta and other major cities on Java. For a family in a remote province, the cost of travel, combined with the psychological toll and the long waiting lists for surgery, can be prohibitive.
Furthermore, the number of pediatric cardiologists in Indonesia is still far below the ideal ratio for a population of over 270 million people. Expanding the capacity of regional hospitals to perform at least basic cardiac interventions and improving the referral system are essential steps. The government and medical organizations are currently working to increase the number of training programs for specialists and to equip more regional hospitals with the technology needed for early diagnosis.
Public Awareness and Digital Education
Beyond clinical interventions, public education plays a pivotal role. Many parents are unaware that heart disease can affect newborns, often associating heart issues only with the elderly or those with poor lifestyle habits. To bridge this knowledge gap, Dr. Rizky and his colleagues have utilized digital platforms to reach a wider audience. The YouTube channel "Sehatkan Jantung Anak Indonesia" serves as a resource for parents and healthcare workers alike, providing information on how to recognize symptoms and the importance of early screening.
The goal is to empower parents to ask for heart screenings at birth and to recognize when their child’s slow weight gain or fatigue might be a sign of something more serious than a common cold or digestive issue. Early detection not only saves lives but also reduces the long-term economic burden on the healthcare system by allowing for earlier, often less complicated, medical management.
Implications for National Health Policy
The high mortality rate associated with CHD in the neonatal period has significant implications for Indonesia’s progress toward the United Nations Sustainable Development Goals (SDGs), specifically the target to end preventable deaths of newborns and children under five years of age. Addressing CHD requires a multi-pronged approach:
- Policy Integration: Integrating pulse oximetry into the standard "Newborn Essential Care" package across all healthcare facilities.
- Vaccination Programs: Strengthening the coverage of the Measles-Rubella (MR) vaccine to eliminate rubella-related birth defects.
- Nutrition: Enhancing food fortification programs and prenatal nutritional counseling.
- Infrastructure Investment: Distributing diagnostic tools like portable echocardiograms to regional centers and training local staff.
In conclusion, while the origins of Congenital Heart Disease may be complex and at times unknown, the path toward reducing its impact is clear. Through a combination of maternal health vigilance, early neonatal screening, and the expansion of specialized medical infrastructure, Indonesia can move toward a future where every child born with a heart defect has a fighting chance at a healthy life. The insights provided by experts like Dr. Rizky Adriansyah underscore that the responsibility lies not just with specialists, but with the entire healthcare ecosystem—from the policy-makers in Jakarta to the midwives in the most remote villages of the archipelago. By focusing on prevention and early detection, the nation can significantly lower the 17 percent mortality rate and ensure that CHD is no longer a silent thief of young lives.
